Jagsi Reshma, Abrahamse Paul, Morrow Monica, Griggs Jennifer J, Schwartz Kendra, Katz Steven J
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109-5010, USA.
Cancer. 2009 Mar 15;115(6):1185-93. doi: 10.1002/cncr.24164.
Given accumulating evidence supporting postmastectomy radiotherapy (PMRT) in selected patients, it is important to evaluate patterns and correlates of PMRT utilization, including communication and attitudinal factors.
The authors surveyed 2382 patients diagnosed with breast cancer in 2002 and reported to the Los Angeles and Detroit Surveillance, Epidemiology, and End Results registries (n=1844, 77.4% response rate). Analyses were restricted to patients with nonmetastatic invasive breast cancer treated by mastectomy who had decided whether or not to undergo PMRT (n=396). The authors assessed rates of explanation, recommendation, and receipt of radiation by indication grouping, defined primarily by the 2001 American Society of Clinical Oncology guidelines. They evaluated correlates of PMRT receipt, including tumor and sociodemographic characteristics. They also explored patients' self-reported reasons for nonreceipt of PMRT.
The adjusted proportion in each indication group reporting that a provider had explained radiation was high (77% of those in whom PMRT was indicated, 76% of those in whom medical opinion was divided, and 73% of those in whom PMRT was not indicated; P=.10). The adjusted proportions reporting recommendations for radiation (86%, 35%, and 17%, respectively) and receipt (81%, 34%, and 10%, respectively) varied significantly by indication grouping (P<.001). On multivariate analysis, tumor size (P<.001), lymph node status (P<.001), comorbidity (P=.02), and chemotherapy receipt (P=.003) were found to be independent significant correlates of PMRT receipt. The most common reasons cited for not pursuing PMRT were lack of physician recommendation and perceived lack of need.
PMRT receipt is strongly correlated with clinical indication. The authors found no sociodemographic disparities in utilization. However, approximately one-fifth of patients with strong indications did not receive treatment.
鉴于越来越多的证据支持对特定患者进行乳房切除术后放疗(PMRT),评估PMRT的使用模式及其相关因素,包括沟通和态度因素,具有重要意义。
作者对2002年诊断为乳腺癌并报告至洛杉矶和底特律监测、流行病学和最终结果登记处的2382例患者进行了调查(n = 1844,应答率77.4%)。分析仅限于接受乳房切除术治疗的非转移性浸润性乳腺癌患者,这些患者已决定是否接受PMRT(n = 396)。作者根据指征分组评估了放疗的解释率、推荐率和接受率,主要依据2001年美国临床肿瘤学会指南进行定义。他们评估了接受PMRT的相关因素,包括肿瘤和社会人口统计学特征。他们还探究了患者自我报告的未接受PMRT的原因。
各指征组中报告医生已解释放疗的校正比例较高(PMRT适用患者中的77%,医学意见存在分歧患者中的76%,PMRT不适用患者中的73%;P = 0.10)。报告放疗推荐(分别为86%、35%和17%)和接受放疗(分别为81%、34%和10%)的校正比例因指征分组而有显著差异(P < 0.001)。多变量分析发现,肿瘤大小(P < 0.001)、淋巴结状态(P < 0.001)、合并症(P = 0.02)和接受化疗情况(P = 0.003)是接受PMRT的独立显著相关因素。未进行PMRT最常见的原因是缺乏医生推荐以及认为没有必要。
接受PMRT与临床指征密切相关。作者未发现使用方面的社会人口统计学差异。然而,约五分之一有强烈指征的患者未接受治疗。